Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study

Ann Oncol. 2008 Nov;19(11):1980-1. doi: 10.1093/annonc/mdn662.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorption
  • Administration, Oral
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / pharmacokinetics*
  • Capecitabine
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacokinetics
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / pharmacokinetics
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Tablets
  • Therapeutic Equivalency

Substances

  • Antimetabolites, Antineoplastic
  • Tablets
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil